Black Diamond Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:BDTX) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 11.32 M15.05 M53.41 M-9.16 M-7.85 M 51.46 M Cash from investing activities -2.19 M6.17 M8.55 M42.06 M-8.59 M 48.18 M Cash from financing activities -252 K291 K32 K52 K-34 K 341 K Free cash flow 11.32 M15.05 M53.41 M-9.16 M-7.85 M 51.46 M

뉴스

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

What Makes Black Diamond (BDTX) a New Strong Buy Stock

New Strong Buy Stocks for January 9th

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

블랙 다이아몬드 테라퓨틱스, Stifel ’매수’ 등급 재확인, 목표가 8달러

Stifel reiterates Buy rating on Black Diamond Therapeutics stock at $8

This PayPal Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Black Diamond Therapeutic (NASDAQ:BDTX), EastGroup Properties (NYSE:EGP)

Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data - Black Diamond Therapeutic (NASDAQ:BDTX)

실베르티닙, 희귀 돌연변이 폐암 환자에서 60% 반응률 보여

Silevertinib shows 60% response rate in lung cancer patients with rare mutations

US Stocks Mixed; Dollar Tree Posts Upbeat Earnings - Black Diamond Therapeutic (NASDAQ:BDTX), Capricor Therapeutics (NASDAQ:CAPR)

Black Diamond to present Phase 2 silevertinib trial results